217 related articles for article (PubMed ID: 32422389)
1. The antidiabetic drug lobeglitazone has the potential to inhibit PTP1B activity.
Rocha RF; Rodrigues T; Menegatti ACO; Bernardes GJL; Terenzi H
Bioorg Chem; 2020 Jul; 100():103927. PubMed ID: 32422389
[TBL] [Abstract][Full Text] [Related]
2. Thiazolidinedione derivatives as PTP1B inhibitors with antihyperglycemic and antiobesity effects.
Bhattarai BR; Kafle B; Hwang JS; Khadka D; Lee SM; Kang JS; Ham SW; Han IO; Park H; Cho H
Bioorg Med Chem Lett; 2009 Nov; 19(21):6161-5. PubMed ID: 19783142
[TBL] [Abstract][Full Text] [Related]
3. α-Methyl artoflavanocoumarin from Juniperus chinensis exerts anti-diabetic effects by inhibiting PTP1B and activating the PI3K/Akt signaling pathway in insulin-resistant HepG2 cells.
Jung HJ; Seong SH; Ali MY; Min BS; Jung HA; Choi JS
Arch Pharm Res; 2017 Dec; 40(12):1403-1413. PubMed ID: 29177868
[TBL] [Abstract][Full Text] [Related]
4. Potential Inhibitors of Protein Tyrosine Phosphatase (PTP1B) Enzyme: Promising Target for Type-II Diabetes Mellitus.
Nandi S; Saxena M
Curr Top Med Chem; 2020; 20(29):2692-2707. PubMed ID: 32888269
[TBL] [Abstract][Full Text] [Related]
5. Structures of PPARγ complexed with lobeglitazone and pioglitazone reveal key determinants for the recognition of antidiabetic drugs.
Lee MA; Tan L; Yang H; Im YG; Im YJ
Sci Rep; 2017 Dec; 7(1):16837. PubMed ID: 29203903
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, biological evaluation and in silico studies of 5-(3-methoxybenzylidene)thiazolidine-2,4-dione analogues as PTP1B inhibitors.
Mahapatra MK; Kumar R; Kumar M
Bioorg Chem; 2017 Apr; 71():1-9. PubMed ID: 28126289
[TBL] [Abstract][Full Text] [Related]
7. Molecular Docking, In-Silico ADMET Study and Development of 1,6- Dihydropyrimidine Derivative as Protein Tyrosine Phosphatase Inhibitor: An Approach to Design and Develop Antidiabetic Agents.
Patel AD; Barot R; Parmar I; Panchal I; Shah U; Patel M; Mishtry B
Curr Comput Aided Drug Des; 2018; 14(4):349-362. PubMed ID: 29701158
[TBL] [Abstract][Full Text] [Related]
8. Identification of 1,3,4-Thiadiazolyl-Containing Thiazolidine-2,4-dione Derivatives as Novel PTP1B Inhibitors with Antidiabetic Activity.
Li M; Li H; Min X; Sun J; Liang B; Xu L; Li J; Wang SH; Xu X
J Med Chem; 2024 May; 67(10):8406-8419. PubMed ID: 38723203
[TBL] [Abstract][Full Text] [Related]
9. Fumosorinone, a novel PTP1B inhibitor, activates insulin signaling in insulin-resistance HepG2 cells and shows anti-diabetic effect in diabetic KKAy mice.
Liu ZQ; Liu T; Chen C; Li MY; Wang ZY; Chen RS; Wei GX; Wang XY; Luo DQ
Toxicol Appl Pharmacol; 2015 May; 285(1):61-70. PubMed ID: 25796170
[TBL] [Abstract][Full Text] [Related]
10. 2-Acyl-3-carboxyl-tetrahydroisoquinoline Derivatives: Mixed-Type PTP1B Inhibitors without PPARγ Activation.
Morishita K; Shoji Y; Fukui M; Ito Y; Kitao T; Ozawa SI; Hirono S; Shirahase H
Chem Pharm Bull (Tokyo); 2018; 66(12):1131-1152. PubMed ID: 30504630
[TBL] [Abstract][Full Text] [Related]
11. Structural Basis for the Enhanced Anti-Diabetic Efficacy of Lobeglitazone on PPARγ.
Jang JY; Bae H; Lee YJ; Choi YI; Kim HJ; Park SB; Suh SW; Kim SW; Han BW
Sci Rep; 2018 Jan; 8(1):31. PubMed ID: 29311579
[TBL] [Abstract][Full Text] [Related]
12. Design and evaluation of non-carboxylate 5-arylidene-2-thioxo-4-imidazolidinones as novel non-competitive inhibitors of protein tyrosine phosphatase 1B.
Ottanà R; Paoli P; Lori G; Adornato I; Previti S; Naß A; Wolber G; Maccari R
Bioorg Chem; 2019 Nov; 92():103211. PubMed ID: 31491569
[TBL] [Abstract][Full Text] [Related]
13. A Library of Thiazolidin-4-one Derivatives as Protein Tyrosine Phosphatase 1B (PTP1B) Inhibitors: An Attempt To Discover Novel Antidiabetic Agents.
Patel AD; Pasha TY; Lunagariya P; Shah U; Bhambharoliya T; Tripathi RKP
ChemMedChem; 2020 Jul; 15(13):1229-1242. PubMed ID: 32390300
[TBL] [Abstract][Full Text] [Related]
14. Novel Non-carboxylate Benzoylsulfonamide-Based Protein Tyrosine Phosphatase 1B Inhibitors with Non-competitive Actions.
Morishita K; Shoji Y; Tanaka S; Fukui M; Ito Y; Kitao T; Ozawa SI; Hirono S; Shirahase H
Chem Pharm Bull (Tokyo); 2017; 65(12):1144-1160. PubMed ID: 29199219
[TBL] [Abstract][Full Text] [Related]
15. 2,4-Thiazolidinediones as PTP 1B Inhibitors: A Mini Review (2012-2018).
Verma SK; Yadav YS; Thareja S
Mini Rev Med Chem; 2019; 19(7):591-598. PubMed ID: 30968766
[TBL] [Abstract][Full Text] [Related]
16. PTP1b Inhibition, A Promising Approach for the Treatment of Diabetes Type II.
Eleftheriou P; Geronikaki A; Petrou A
Curr Top Med Chem; 2019; 19(4):246-263. PubMed ID: 30714526
[TBL] [Abstract][Full Text] [Related]
17. Docking Assisted Prediction and Biological Evaluation of Sideritis L. Components with PTP1b Inhibitory Action and Probable Anti-Diabetic Properties.
Eleftheriou P; Therianou E; Lazari D; Dirnali S; Micha A
Curr Top Med Chem; 2019; 19(5):383-392. PubMed ID: 30806317
[TBL] [Abstract][Full Text] [Related]
18. Trivaric acid, a new inhibitor of PTP1b with potent beneficial effect on diabetes.
Sun W; Zhang B; Zheng H; Zhuang C; Li X; Lu X; Quan C; Dong Y; Zheng Z; Xiu Z
Life Sci; 2017 Jan; 169():52-64. PubMed ID: 27871946
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of PTP1B by farnesylated 2-arylbenzofurans isolated from Morus alba root bark: unraveling the mechanism of inhibition based on in vitro and in silico studies.
Ha MT; Shrestha S; Tran TH; Kim JA; Woo MH; Choi JS; Min BS
Arch Pharm Res; 2020 Sep; 43(9):961-975. PubMed ID: 32978714
[TBL] [Abstract][Full Text] [Related]
20. Toward a treatment of diabesity: Rational design, synthesis and biological evaluation of benzene-sulfonamide derivatives as a new class of PTP-1B inhibitors.
Ghareb N; El-Sayed NM; Abdelhameed R; Yamada K; Elgawish MS
Bioorg Chem; 2019 May; 86():322-338. PubMed ID: 30743173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
